Prognostic value of Ki-67 immunolabelling in primary operable breast cancer - Wikidata - wikimedia - TriplyDB

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

http://www.wikidata.org/entity/Q35976565

about

The prognostic relevance of estimates of proliferative activity in early breast cancer.The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer.A high proliferative index of recurrent melanoma is associated with worse survival Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review Ki-67 biomarker in breast cancer of Indian women Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators MIB-1 labelling index is an independent prognostic marker in primary breast cancer.Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma.The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus.Breast carcinomas occurring in young women (< 35 years) are different.Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Immunohistochemical assessment of primary breast tumors and metachronous brain metastases, with particular regard to differences in the expression of biological markers and prognosis Ki-67 and caspase expression in breast carcinoma: does variance in locational sampling exist?Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy.Prognostic value of proliferation markers: immunohistochemical ki-67 expression and cytometric s-phase fraction of women with breast cancer in libya Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material.Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma.Histamine, mast cells and tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect?Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.The anticancer effect of PQ1 in the MMTV-PyVT mouse model.The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR.Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer.p34cdc2 in invasive breast cancer: relationship to DNA content, Ki67 index and c-erbB-2 expression.A literature-based approach to evaluate the predictive capacity of a marker using time-dependent summary receiver operating characteristics.Ki-67 and PCNA Expression in Canine Mammary Tumors and Adjacent Nonneoplastic Mammary Glands: Prognostic Impact by a Multivariate Survival Analysis.Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.Canine mammary tumors as a model for human disease.

P2860

Q31028293-10C65943-9476-4DE1-BE7A-92D8C7EA9E12 Q33610032-C52A64D2-88A4-4327-BFE8-9B649EF242CC Q35012858-93238F1A-CAB5-46C1-A072-DC5AB82EAC88 Q35089965-A7F18B0D-7499-488B-9BC1-CE434DEE069F Q35157568-4753EC40-509C-4E8E-BAE4-14B1558A8815 Q35904441-E7546A11-EADE-4833-BE94-DDC1289C602D Q35913434-97737BC6-3377-4CB2-9204-5A6E39FA105E Q36081213-2CC71292-381F-4E1B-AE0F-38EC73705984 Q36115384-23B19F3E-8B5C-4AE2-A8AD-42DD75287A9D Q36136005-3FE3992D-273B-415C-8A33-3DA6FEAFF6F8 Q36141048-16F03DC2-362D-49F6-B1B9-435ECED08971 Q36141250-BC1C6D93-B1CF-4799-9C93-999F32852756 Q36175746-6FC3794C-8D62-4DBE-BBB2-02EF7756CE0C Q36244120-26A15240-B81D-474F-9BCA-C58780959666 Q36261767-1AEE183C-AC13-4483-81F4-1CCD50317DEF Q36291690-FF850801-4A2E-4F62-B317-46F255FDB8C0 Q36292397-8B3E9E06-402A-4C31-8497-24FFDB58A667 Q36316597-C81DF1A4-B8C0-4DDC-B7F3-B59059A2E666 Q36422395-40C57C99-E681-4636-90C2-7725EBDD9A9F Q36609527-9A312630-4923-44DF-B8D0-096694C0E501 Q36618793-01F1CCE0-265D-4311-91FB-63B849D5E791 Q36620807-94460F08-3396-499A-AB6D-0B78DAB64319 Q37199637-4265C84E-0AF7-43C0-A035-2E564A1A7FF8 Q37628148-C942F3C8-9B65-4EB2-9D7C-CF0F963F0A8E Q41736712-464B4CE1-9BE7-4CC8-9245-1BB817872F3C Q43743504-68E678EC-88D1-45FD-B88F-03640F55802B Q43907667-D116FF9F-6BAD-41BE-89FA-650B89C946A1 Q44840763-E764978B-A35A-4756-974C-FF00FB60C67A Q45141248-8D5E2C00-3254-453B-B5FB-9FED138D2B9F Q53104819-79FE34D2-AACC-4419-B2DB-3EB60F8048CE Q54577077-73BBDB8A-A813-4EA8-B70E-B3A5558778B5 Q55368630-881D86A3-0FD2-4B95-96EB-A58AE4A278DB

P2860

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

http://www.wikidata.org/entity/Q35976565

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年学术文章

@wuu

1993年学术文章

@zh-cn

1993年学术文章

@zh-hans

1993年学术文章

@zh-my

1993年学术文章

@zh-sg

1993年學術文章

@yue

1993年學術文章

@zh

1993年學術文章

@zh-hant

name

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

@ast

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

@en

type

label

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

@ast

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

@en

prefLabel

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

@ast

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

@en

P1433

Q35976565-235BD7DB-B8EE-44F1-92EB-95234F5E0856

P1476

Q35976565-D83F2699-67C3-454B-9DDE-9B28C26BB0D9

P2093

Q35976565-0968E4E4-5D7D-47C3-8AE9-299E6126731E

Q35976565-691B31CF-2F11-47B9-BCB4-18F0CC2BAC07

Q35976565-958608ED-9036-4373-8457-54B3BFECED0E

Q35976565-B04C9D83-5C42-4C37-8815-D001E703C48D

Q35976565-B22435E3-0E1E-40B8-A07A-1CF1773BBEDA

Q35976565-B405EDEE-15DA-4A0B-9F6B-1F7F76426B42

P2860

Q35976565-38273B7F-D239-4385-B85E-7718EA2B4A55

Q35976565-4FE3AEA9-C25F-4A03-A3EC-0E7FA2DA7AF3

Q35976565-51100479-484B-4C7B-8AD6-160AE8A8F824

Q35976565-5BF69154-7BFE-4834-9F35-47C9D7A3B27A

Q35976565-961E6F2A-47CE-4D89-87E6-622636890ED2

Q35976565-F89E5DC1-5C10-4B83-95E6-B9EA7DFE42E9

P2888

Q35976565-0C3AB6F5-E62B-4E2F-82D1-BB808885497E

P304

Q35976565-231EE252-558F-4775-BE8F-AE17D6222F19

P31

Q35976565-BAFC54C9-743B-49E0-A7A3-A690D27DC4C5

P356

Q35976565-E9EAF3B0-7783-4C0F-84AD-9B12D64CE49C

P407

Q35976565-D360F938-8A9E-4C01-A683-95E8AA1931B6

P433

Q35976565-860A7F10-F9D0-4AA1-84F1-57FCA035DE90

P478

Q35976565-5C1C6FAC-9452-4B63-BF7C-4394B0EBA386

P577

Q35976565-29C2ADF8-ECC3-460F-9C32-764630D29250

P5875

Q35976565-8B1D286C-3951-4923-8501-040D1DC0B7C9

P698

Q35976565-E0389926-17AF-4C72-AB9F-1F558CE94F20

P932

Q35976565-0FBEFBA8-D3C6-4D7E-B5AC-9A61477BA4E8

P356

P1433

British Journal of Cancer

P1476

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer

@en

P2093

Kyllönen L

http://www.w3.org/2001/XMLSchema#string

Leivonen M

http://www.w3.org/2001/XMLSchema#string

Nordling S

http://www.w3.org/2001/XMLSchema#string

Railo M

http://www.w3.org/2001/XMLSchema#string

von Boguslawsky K

http://www.w3.org/2001/XMLSchema#string

von Smitten K

http://www.w3.org/2001/XMLSchema#string

P2860

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Evaluation of the prognostic value of triple node biopsy in early breast cancer.

Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma.

P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia.

Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry.

P2888

P304

579-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1993.389

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P577

1993-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14804040

http://www.w3.org/2001/XMLSchema#string

P698

8394732

http://www.w3.org/2001/XMLSchema#string

P932

1968381

http://www.w3.org/2001/XMLSchema#string